ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 2429

$690K Total Retail Price of All Prescriptions

Rank: 125 out of 2429

305 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

27% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 7,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 459 174 S3 1 6
LISINOPRIL 378 288 2 2
METOPROLOL TARTRATE 324 223 3 9
OMEPRAZOLE 298 234 4 7
LEVOTHYROXINE SODIUM 256 173 5 3
METFORMIN HCL 253 189 6 8
FUROSEMIDE 243 190 7 5
POTASSIUM CHLORIDE 229 155 8 14
ATORVASTATIN CALCIUM 222 152 9 13
CITALOPRAM HBR 217 178 10 19
AMLODIPINE BESYLATE 193 159 11 4
PRAVASTATIN SODIUM 183 153 12 16
SIMVASTATIN 176 139 13 1
ISOSORBIDE MONONITRATE ER 147 107 14 55
PANTOPRAZOLE SODIUM 146 78 15 34
METOPROLOL SUCCINATE 139 121 16 12
WARFARIN SODIUM 136 110 17 11
CYMBALTA 135 73 18 58
PROAIR HFA 130 46 19 41
CRESTOR 128 55 20 25
CHLORTHALIDONE 120 86 21 182
DONEPEZIL HCL 118 118 22 26
TRAZODONE HCL 118 77 22 50
FENOFIBRATE 118 71 22 48
RANITIDINE HCL 113 73 25 24
SERTRALINE HCL 109 80 26 23
CLOPIDOGREL 108 79 27 31
GLIMEPIRIDE 102 75 28 51
TRAMADOL HCL 100 57 29 17
NAMENDA 99 99 30 35
LOSARTAN POTASSIUM 99 84 30 22
PREDNISONE 98 73 32 38
ALENDRONATE SODIUM 95 87 33 20
IBUPROFEN 94 25 34 57
DIOVAN 90 50 35 36
FENTANYL 84 24 S2 36 59
CARBIDOPA-LEVODOPA 83 54 37 88
ADVAIR DISKUS 83 39 37 49
QVAR 79 32 39 314
CYCLOBENZAPRINE HCL 79 0 R 39 69
ZOLPIDEM TARTRATE 78 36 41 28
OXYBUTYNIN CHLORIDE ER 77 62 42 79
ESCITALOPRAM OXALATE 76 64 43 74
CARVEDILOL 75 65 44 21
ALLOPURINOL 74 50 45 33
PLAVIX 74 63 45 44
ZETIA 70 47 47 70
AZITHROMYCIN 69 43 48 46
ACETAMINOPHEN-CODEINE 67 35 S3 49 82
SPIRIVA 66 45 50 54
PROPRANOLOL HCL 64 21 51 119
BUSPIRONE HCL 61 38 52 160
POLYETHYLENE GLYCOL 3350 59 36 53 56
HYDROCHLOROTHIAZIDE 58 46 54 10
CLONIDINE HCL 55 55 55 68
NAPROXEN 55 32 55 75
VENLAFAXINE HCL ER 54 32 57 98
ROPINIROLE HCL 51 33 58 92
TRICOR 50 37 59 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.